Expertise in
1
conditions

Deepak Singhal

Port Road, 
Adelaide, SA, AU 
Expertise in
1
conditions
Port Road, 
Adelaide, SA, AU 

Overview

Deepak Singhal practices practicing medicine in Adelaide, Australia.

Mr. Singhal is highly rated in 1 condition, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Leukemia, Acute Myeloid Leukemia (AML), RUNX1 Familial Platelet Disorder, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Port Road, Adelaide, SA, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3

27 Total Publications

Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.
Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.
Journal: Transplantation and cellular therapy
Published: November 13, 2025

Frequently Asked Questions about Deepak Singhal

Is Deepak Singhal a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Deepak Singhal is classified as an Advanced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Deepak Singhal participate in research or clinical trials?

Yes. Deepak Singhal has published 27 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Deepak Singhal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Singhal's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile